Successfully reported this slideshow.
Encephalitis Global Clinical Trials Review, H2, 2012Report Details:Published:September 2012No. of Pages: 89Price: Single U...
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesGet your copy of this repor...
Biological E. Limited 35Clinical Trial Overview of Biological E. Limited 35Pfizer Inc. 36Clinical Trial Overview of Pfizer...
Clinical Trial Overview of University Hospital, Bonn 55General Hospital of Chinese Armed Police Forces 56Clinical Trial Ov...
Encephalitis Therapeutics Clinical Trials, G7 Countries, 2012* 15Encephalitis Therapeutics Market, G7 Countries, Clinical ...
Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012*47Encephalitis Therape...
Encephalitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10Encephalitis Therapeutics ...
Upcoming SlideShare
Loading in …5
×

Encephalitis Global Clinical Trials Review, H2, 2012

164 views

Published on

  • Be the first to comment

  • Be the first to like this

Encephalitis Global Clinical Trials Review, H2, 2012

  1. 1. Encephalitis Global Clinical Trials Review, H2, 2012Report Details:Published:September 2012No. of Pages: 89Price: Single User License – US$2500Encephalitis Global Clinical Trials Review, H2, 2012SummaryGlobalDatas clinical trial report, “Encephalitis Global Clinical Trials Review, H2, 2012" providesdata on the Encephalitis clinical trial scenario. This report provides elemental information and datarelating to the clinical trials on Encephalitis. It includes an overview of the trial numbers and theirrecruitment status as per the site of trial conduction across the globe. The databook offers apreliminary coverage of disease clinical trials by their phase, trial status, prominence of thesponsors and also provides briefing pertaining to the number of trials for the key drugs for treatingEncephalitis. This report is built using data and information sourced from proprietary databases,primary and secondary research and in-house analysis by GlobalDatas team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability andrelevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America,Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, alongwith the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited andsponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location,sponsor type and many more- Obtain discontinued trial listing for trials across the globe
  2. 2. - Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesGet your copy of this report @http://www.reportsnreports.com/reports/197461-encephalitis-global-clinical-trials-review-h2-2012.htmlMajor points covered in Table of Contents of this report includeTable of ContentsTable of Contents 2List of Tables 4List of Figures 6Introduction 7Encephalitis 7Report Guidance 7Clinical Trials by Region 8Clinical Trials by Country 9Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11Top Five Countries Contributing to Clinical Trials in Europe 12Top Countries Contributing to Clinical Trials in North America 13Clinical Trials by BRIC Nations 14Clinical Trials by G7 Nations 15Clinical Trials in G7 Nations by Trial Status 16Clinical Trials by E7 Nations 17Clinical Trials in E7 Nations by Trial Status 18Clinical Trials by Phase 19In Progress Trials by Phase 20Clinical Trials by Trial Status 21Unaccomplished Trials of Encephalitis 22Subjects Recruited Over a Period of Time 23Prominent Sponsors 24Top Companies Participating in Encephalitis Therapeutics Clinical Trials 26Prominent Drug Comparison 28Clinical Trial Profiles 29Clinical Trial Overview of Top Companies 29Intercell AG 29Clinical Trial Overview of Intercell AG 29Sanofi 31Clinical Trial Overview of Sanofi 31Baxter International Inc. 32Clinical Trial Overview of Baxter International Inc. 32Baxter Healthcare Corporation 33Clinical Trial Overview of Baxter Healthcare Corporation 33Novartis AG 34Clinical Trial Overview of Novartis AG 34
  3. 3. Biological E. Limited 35Clinical Trial Overview of Biological E. Limited 35Pfizer Inc. 36Clinical Trial Overview of Pfizer Inc. 36BIOVOMED 37Clinical Trial Overview of BIOVOMED 37Novartis Vaccines & Diagnostics (HK) Ltd. 38Clinical Trial Overview of Novartis Vaccines & Diagnostics (HK) Ltd. 38Sarepta Therapeutics, Inc. 39Clinical Trial Overview of Sarepta Therapeutics, Inc. 39A. Menarini Industrie Farmaceutiche Riunite Srl 40Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 40DynPort Vaccine Company LLC 41Clinical Trial Overview of DynPort Vaccine Company LLC 41MacroGenics, Inc. 42Clinical Trial Overview of MacroGenics, Inc. 42Bharat Biotech International Limited 43Clinical Trial Overview of Bharat Biotech International Limited 43Baxter Deutschland GmbH 44Clinical Trial Overview of Baxter Deutschland GmbH 44Boryung Pharmaceutical Co., Ltd. 45Clinical Trial Overview of Boryung Pharmaceutical Co., Ltd. 45GlaxoSmithKline plc 46Clinical Trial Overview of GlaxoSmithKline plc 46Clinical Trial Overview of Top Universities / Institutes / Hospitals 47Emory University 47Clinical Trial Overview of Emory University 47Imperial College London 48Clinical Trial Overview of Imperial College London 48Medical University of Vienna 49Clinical Trial Overview of Medical University of Vienna 49University of Michigan 50Clinical Trial Overview of University of Michigan 50Norwegian University of Science and Technology 51Clinical Trial Overview of Norwegian University of Science and Technology 51Vanderbilt University 52Clinical Trial Overview of Vanderbilt University 52University of Rochester 53Clinical Trial Overview of University of Rochester 53Assistance Publique - Hopitaux de Paris 54Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 54University Hospital, Bonn 55
  4. 4. Clinical Trial Overview of University Hospital, Bonn 55General Hospital of Chinese Armed Police Forces 56Clinical Trial Overview of General Hospital of Chinese Armed Police Forces 56Malar Hospital 57Clinical Trial Overview of Malar Hospital 57Belarusian State Technological University 58Clinical Trial Overview of Belarusian State Technological University 58Mennonite Christian Hospital 59Clinical Trial Overview of Mennonite Christian Hospital 59Elisabethinen Hospital 60Clinical Trial Overview of Elisabethinen Hospital 60California Pacific Medical Center 61Clinical Trial Overview of California Pacific Medical Center 61ICDDR,B 62Clinical Trial Overview of ICDDR,B 62Helsinki University Central Hospital 63Clinical Trial Overview of Helsinki University Central Hospital 63University Medical Centre Ljubljana 64Clinical Trial Overview of University Medical Centre Ljubljana 64London School of Hygiene & Tropical Medicine 65Clinical Trial Overview of London School of Hygiene & Tropical Medicine 65The University of Melbourne 66Clinical Trial Overview of The University of Melbourne 66Five Key Clinical Profiles 67Appendix 86Abbreviations 86Definitions 86Research Methodology 87Secondary Research 88About GlobalData 88Contact Us 88Disclaimer 88Source 89List of TablesEncephalitis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8Encephalitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9Encephalitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10Encephalitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11Encephalitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12Encephalitis Therapeutics Clinical Trials, North America, Top Countries, 2012* 13Encephalitis Therapeutics Clinical Trials, BRIC Countries, 2012* 14
  5. 5. Encephalitis Therapeutics Clinical Trials, G7 Countries, 2012* 15Encephalitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16Encephalitis Therapeutics Clinical Trials, E7 Countries, 2012* 17Encephalitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18Encephalitis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19Encephalitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20Encephalitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21Encephalitis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 22Encephalitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-201123Encephalitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25Encephalitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27Encephalitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercell AG, 2012* 29Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 31Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc.,2012* 32Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter HealthcareCorporation, 2012* 33Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 34Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Biological E. Limited,2012* 35Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 36Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOVOMED, 2012* 37Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Vaccines &Diagnostics (HK) Ltd., 2012* 38Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics,Inc., 2012* 39Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini IndustrieFarmaceutiche Riunite Srl, 2012* 40Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by DynPort VaccineCompany LLC, 2012* 41Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc.,2012* 42Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bharat BiotechInternational Limited, 2012* 43Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter DeutschlandGmbH, 2012* 44Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boryung PharmaceuticalCo., Ltd., 2012* 45Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc,2012* 46
  6. 6. Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012*47Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial CollegeLondon, 2012* 48Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University ofVienna, 2012* 49Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan,2012* 50Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University ofScience and Technology, 2012* 51Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University,2012* 52Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester,2012* 53Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique -Hopitaux de Paris, 2012* 54Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital,Bonn, 2012* 55Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by General Hospital ofChinese Armed Police Forces, 2012* 56Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Malar Hospital, 2012* 57Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Belarusian StateTechnological University, 2012* 58Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mennonite ChristianHospital, 2012* 59Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Elisabethinen Hospital,2012* 60Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by California PacificMedical Center, 2012* 61Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ICDDR,B, 2012* 62Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki UniversityCentral Hospital, 2012* 63Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University MedicalCentre Ljubljana, 2012* 64Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by London School ofHygiene & Tropical Medicine, 2012* 65Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University ofMelbourne, 2012* 66List of FiguresEncephalitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8Encephalitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
  7. 7. Encephalitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10Encephalitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11Encephalitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12Encephalitis Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13Encephalitis Therapeutics Clinical Trials, BRIC Countries (%), 2012* 14Encephalitis Therapeutics Clinical Trials, G7 Countries (%), 2012* 15Encephalitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16Encephalitis Therapeutics Clinical Trials, E7 Countries (%), 2012* 17Encephalitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18Encephalitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19Encephalitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20Encephalitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21Encephalitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-201123Encephalitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24Encephalitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26Encephalitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28GlobalData Methodology 87Contact: sales@reportsandreports.com for more information.

×